Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.

Saved in:
Bibliographic Details
Title: Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.
Authors: Chi BH (AUTHOR), Sinkala M (AUTHOR), Mbewe F (AUTHOR), Cantrell RA (AUTHOR), Kruse G (AUTHOR), Chintu N (AUTHOR), Aldrovandi GM (AUTHOR), Stringer EM (AUTHOR), Kankasa C (AUTHOR), Safrit JT (AUTHOR), Stringer JS (AUTHOR)
Source: Lancet. 11/17/2007, Vol. 370 Issue 9600, p1698-1705. 8p.
Database: Psychology and Behavioral Sciences Collection
Description
ISSN:01406736
DOI:10.1016/s0140-6736(07)61605-5